![Erythromycin estolate t III 2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M14480_1631097445.gif?v=1631097447)
Pay in 4 interest-free payments of $24.40 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide
26 mg/mL(100 mM)
It has improved PK properties relative to UNC0638 and displayed modest brain penetration in vivo
InChi: InChI=1S/C27H33N5O2/c1-27(2
anti-ulcer activities
Erythromycin estolate t III 2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamideErythromycin estolate, erythromycin derivative, is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport. Product information CAS Number: 3521 62 8 Molecular Weight: 1056. 39 Formula: C52H97NO18S Chemical Name: (2S,3R,4S,6R) 4
US$ 139.00
US$ 1854.50
US$ 2521.50
US$ 199.00
US$ 114.50
US$ 114.50
US$ 199.00
US$ 189.00
US$ 199.00